Seed · Biotech · London, United Kingdom · Founded 2019 · 11–50 employees
Micrographia Bio is a London-based applied AI-first life sciences company pioneering a new era of drug discovery through spatial proteomics. By visualising proteins in their native, spatial nano-scale cellular context, they aim to uncover the true mechanisms of action of drug candidates, enhancing the probability of success in drug discovery. Founded in 2019 by CEO Julia Fan Li and CTO Chris Thompson, the company has raised approximately £6.57 million in funding and is advancing internal therapeutic candidates focused on fundamental cellular pathways.
No open roles listed right now.